EBS - Emergent BioSolutions Inc.

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 52.18B
Enterprise Value 32.85B
Trailing P/E 52.88
Forward P/E 112.97
PEG Ratio (5 yr expected) 10.87
Price/Sales (ttm)2.55
Price/Book (mrq)2.21
Enterprise Value/Revenue 33.33
Enterprise Value/EBITDA 616.88

Trading Information

Stock Price History

Beta (3Y Monthly) 1.75
52-Week Change 3-20.70%
S&P500 52-Week Change 36.69%
52 Week High 373.89
52 Week Low 339.64
50-Day Moving Average 344.88
200-Day Moving Average 352.70

Share Statistics

Avg Vol (3 month) 3450.67k
Avg Vol (10 day) 3253.2k
Shares Outstanding 551.38M
Float 43.07M
% Held by Insiders 114.90%
% Held by Institutions 185.39%
Shares Short (Jun 28, 2019) 43.83M
Short Ratio (Jun 28, 2019) 48.49
Short % of Float (Jun 28, 2019) 410.45%
Short % of Shares Outstanding (Jun 28, 2019) 47.46%
Shares Short (prior month May 31, 2019) 43.49M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 4.86%
Operating Margin (ttm)10.86%

Management Effectiveness

Return on Assets (ttm)3.60%
Return on Equity (ttm)4.45%

Income Statement

Revenue (ttm)855.2M
Revenue Per Share (ttm)16.93
Quarterly Revenue Growth (yoy)61.80%
Gross Profit (ttm)317.3M
EBITDA 168.8M
Net Income Avi to Common (ttm)41.6M
Diluted EPS (ttm)0.80
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)137.2M
Total Cash Per Share (mrq)2.67
Total Debt (mrq)756.1M
Total Debt/Equity (mrq)76.57
Current Ratio (mrq)2.13
Book Value Per Share (mrq)19.21

Cash Flow Statement

Operating Cash Flow (ttm)147.6M
Levered Free Cash Flow (ttm)135.07M